Law360, New York ( August 5, 2013, 1:43 PM EDT) -- On June 13, 2013, the United States Supreme Court issued its long-awaited decision in Association for Molecular Pathology v. Myriad Genetics Inc., and held that isolated genes are not patent eligible subject matter under 35 U.S.C. § 101. 569 U.S. ___, slip. op. at 13, 17 (2013). To reach this conclusion, the court relied on Funk Brothers Seed Co. v. Kalo Inoculant Co., 333 U.S. 127 (1948), a case in which a patent for a mixture of bacteria was held invalid because the mixture "fell short of invention." Although the Supreme Court treats Funk Brothers as a patent-eligibility case, arguably, Funk Brothers, like other "lack of invention" cases, may be more accurately classified as an obviousness case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.